THE EFFECT OF THE PLATELET-ACTIVATING-FACTOR INHIBITOR TCV-309 ON REPERFUSION INJURY IN A CANINE MODEL OF ISCHEMIC LUNG

被引：5
|
作者：
KAWAHARA, K
TAGAWA, T
TAKAHASHI, T
AKAMINE, S
NAKAMURA, A
YAMAMOTO, S
MURAOKA, S
TOMITA, M
机构：
[1] The First Department of Surgery, Nagasaki University School of Medicine, Nagasaki
来源：
TRANSPLANTATION | 1993年 / 55卷 / 06期
关键词：
D O I：
10.1097/00007890-199306000-00045
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1438 / 1439
页数：2
相关论文
共 50 条
  • [1] BENEFICIAL EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 ON RENAL ISCHEMIA-REPERFUSION INJURY
    YIN, M
    KURVERS, HAJM
    BUURMAN, WA
    TANGELDER, GJ
    BOOSTER, MH
    DAEMEN, JHC
    KONDRACKI, S
    KOOTSTRA, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 774 - 776
  • [2] ROLE OF PLATELET-ACTIVATING-FACTOR IN ISCHEMIA-REPERFUSION INJURY OF ISOLATED RABBIT HEARTS - PROTECTIVE EFFECT OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST, TCV-309
    KATOH, S
    TOYAMA, J
    KODAMA, I
    KOIKE, A
    ABE, T
    CARDIOVASCULAR RESEARCH, 1993, 27 (08) : 1430 - 1434
  • [3] THE EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 ON ARRHYTHMIAS AND FUNCTIONAL RECOVERY DURING MYOCARDIAL REPERFUSION
    TAMURA, K
    KIMURA, Y
    TAMURA, T
    KITASHIRO, S
    IZUOKA, T
    TSUJI, H
    IWASAKA, T
    INADA, M
    CORONARY ARTERY DISEASE, 1994, 5 (03) : 267 - 273
  • [4] PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 PROTECTS RAT KIDNEYS AGAINST ISCHEMIA-REPERFUSION INJURY
    YIN, M
    KURVERS, HAJM
    BUURMAN, WA
    TANGELDER, GJ
    TIEBOSCH, ATM
    DAEMEN, JHC
    KOOTSTRA, G
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 2844 - 2846
  • [5] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST (TCV-309) ON LUNG INJURY IN DOGS WITH EXPERIMENTALLY ENDOTOXIN-INDUCED SHOCK
    OKANO, S
    TAGAWA, M
    URAKAWA, N
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1995, 57 (04): : 751 - 753
  • [6] EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST, TCV-309, AND THE CYCLOOXYGENASE INHIBITOR, IBUPROFEN, ON THE HEMODYNAMIC-CHANGES IN CANINE EXPERIMENTAL ENDOTOXIC-SHOCK
    YAMANAKA, S
    IWAO, H
    YUKIMURA, T
    KIM, S
    MIURA, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (04) : 1501 - 1507
  • [7] PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS - DEVELOPMENT OF A HIGHLY POTENT PAF ANTAGONIST, TCV-309
    TAKATANI, M
    MAEZAKI, N
    IMURA, Y
    TERASHITA, Z
    NISHIKAWA, K
    TSUSHIMA, S
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1991, 21 : 943 - 946
  • [8] EFFECT OF TCV-309, A NOVEL PLATELET-ACTIVATING-FACTOR ANTAGONIST, ON HEMODYNAMICS IN DOGS WITH ENDOTOXIN-INDUCED SHOCK
    OKANO, S
    TAGAWA, M
    URAKAWA, N
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 1995, 57 (02): : 385 - 387
  • [9] PLATELET-ACTIVATING-FACTOR ANTAGONIST TCV-309 ATTENUATES THE INDUCTION OF THE CYTOKINE NETWORK IN EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES
    KUIPER, B
    VANDERPOLL, T
    LEVI, M
    VANDEVENTER, SJH
    TENCATE, H
    IMAI, Y
    HACK, CE
    TENCATE, JW
    JOURNAL OF IMMUNOLOGY, 1994, 152 (05): : 2438 - 2446
  • [10] BENEFICIAL-EFFECTS OF TCV-309, A NOVEL POTENT AND SELECTIVE PLATELET-ACTIVATING-FACTOR ANTAGONIST IN ENDOTOXIN AND ANAPHYLACTIC SHOCK IN RODENTS
    TERASHITA, ZI
    KAWAMURA, M
    TAKATANI, M
    TSUSHIMA, S
    IMURA, Y
    NISHIKAWA, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (02): : 748 - 755
12345